Indeed, VitD supplementation reduces the high-sensitivity C-reactive protein (hs-CRP) in patients with diabetes [108], psychiatric disorders [109], polycystic ovary syndrome [110], and advanced kidney disease [111], and reduces the tumor necrosis factor-α (TNF-α) in patients with diabetes [112]. Here, TNF is linked to polycystic ovary syndrome.